TITLE

Transforming Growth Factor-beta1 Inhibits Rat Prolactin Promoter Activity in GH[sub 4] Neuroendocrine Cells

AUTHOR(S)
Farrow, Kathryn N.; Gutierrez-Hartmann, Arthur
PUB. DATE
November 1999
SOURCE
DNA & Cell Biology;Nov99, Vol. 18 Issue 11, p863
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The prototypic member of the transforming growth factor beta family is TGFbeta1, which is known to be important in extracellular matrix production, cell proliferation, and cell differentiation. Specifically in the pituitary lactotroph, TGFbeta1 inhibits prolactin (PRL) peptide secretion, PRL mRNA levels, and PRL gene transcription. To further elucidate the molecular details by which TGFbeta1 modulates PRL gene transcription, we used a transient transfection approach to characterize and to map the TGFbeta1 inhibitory response element of the rat (r) PRL promoter. Here, we show that TGFbeta1 selectively inhibits basal rPRL promoter activity in GH[sub 4] cells in a dose-responsive fashion, with an IC[sub 50] of 6 pM, and that this inhibition occurs within 6 h after TGFbeta1 addition. Using a series of 5' deletion promoter mutants, the TGFbeta1 inhibitory response was found to be unaffected by deletion to position -116 and was abrogated by further deletion to -54 in the rPRL promoter. However, on the basis of data from site-specific and linker-scanning mutants of the rPRL promoter, it appears that no single element is sufficient to mediate the TGFbeta1 inhibitory effect. Sequence analysis of the -116/-54 region failed to reveal any sequence homology to previously characterized TGFbeta response elements. Finally, TGFbeta1 failed to alter significantly the endogenous levels of the cell-specific activator protein GHF-1/Pit-1, indicating that the TGFbeta1 inhibitory effect is not attributable to diminished levels of GHF-1/Pit1. Taken together, these data indicate that the TGFbeta1 inhibitory response is more complex than previously appreciated, requiring more than one cis-acting element and not always acting via TTGG or GTCTAGAC sites.
ACCESSION #
6778149

 

Related Articles

  • TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain. Riser, Bruce L.; Ladson-Wofford, Stephanie; Sharba, Abdulkarim; Cortes, Pedro; Drake, Katie; Guerin, Christopher J.; Yee, Jerry; Choi, Mary E.; Segarini, Patricia R.; Narins, Robert G. // Kidney International;Aug1999, Vol. 56 Issue 2, p428 

    TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain. Background. Transforming growth factor-β (TGF-β) is a causal factor in experimental glomerulosclerosis, and it mediates the increased extracellular matrix (ECM) accumulation...

  • Anti-latent TGF-β binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. Hori, Yuichi; Katoh, Tetsuo; Hirakata, Masao; Joki, Nobuhiko; Kaname, Shinya; Fukagawa, Masafumi; Okuda, Toshihiro; Ohashi, Hideya; Fujita, Toshiro; Miyazono, Kohei; Kurokawa, Kiyoshi // Kidney International;Jun1998, Vol. 53 Issue 6, p1616 

    Examines the role of latent transforming growth factor-beta (TGF-beta) binding protein-1 (LTBP-1) in the TGF-beta-mediated extracellular matrix (ECM) expression. Structures of (LTBP-1) and synthetic oligopeptides; Effect of stretch on mRNA expression of ECM components and TGF-beta1;...

  • Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells. Tsuchida, Ken-Ichi; Zhu, Yanqing; Siva, Senthuran; Dunn, Stephen R.; Sharma, Kumar // Kidney International;Jun2003, Vol. 63 Issue 6, p2000 

    Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells. Background. The best characterized signaling pathway employed by transforming growth factor-β (TGF-β) is the Smad pathway; however, its role in matrix production in mesangial cells is unclear. We...

  • Up-regulation of glomerular extracellular matrix and transforming growth factor-β expression in RF/J mice. KAMATA, TADASHI; MUSO, ERI; YASHIRO, MASATOMO; KAWAMURA, TAKAHIDE; OYAMA, ATSUSHI; MATSUSHIMA, HIROYUKI; TAKEUCHI, EIJI; YOSHIDA, HARUYOSHI; SASAYAMA, SHIGETAKE; Muso, Eri // Kidney International;Mar1999, Vol. 55 Issue 3, p864 

    Up-regulation of glomerular extracellular matrix and transforming growth factor-β expression in RF/J mice. Background. RF/J mice were first reported as a murine model of spontaneous glomerulosclerosis by Gude and Lupton in 1960, but the precise histologic characteristics and...

  • Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Li, Jin H.; Huang, Xiao R.; Zhu, Hong-Jian; Johnson, Richard; Lan, Hui Y. // Kidney International;Jun2003, Vol. 63 Issue 6, p2010 

    Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Background. Hyperglycemia has been shown to play an important role in diabetic renal and vascular complications. Some studies show that high glucose may mediate diabetic complications by stimulating...

  • Transforming Growth Factor β Signaling, Vascular Remodeling, and Hypertension. August, Phyllis; Suthanthiran, Manikkam // New England Journal of Medicine;6/22/2006, Vol. 354 Issue 25, p2721 

    The article focuses on a study which explored the role of transforming growth factor-�2 (TGF-�2) and hypertension. TGF-�2 acts as a promoter of fibrosis which established its link to various human diseases such as chronic kidney disease, restenosis after angioplasty,...

  • Regulation of TGF-� Signaling by SMADs and its Roles in Tissue Fibrosis. Fukasawa, Hirotaka; Yamamoto, Tatsuo; Kitagawa, Masatoshi; Hishida, Akira // Current Signal Transduction Therapy;Jan2008, Vol. 3 Issue 1, p1 

    Transforming growth factor-� (TGF-�) is a profibrotic cytokine involved in the accumulation of extracellular matrix proteins and progression of various fibrotic diseases. TGF-� signaling is transmitted predominantly through cell surface serine/threonine kinase receptors to...

  • PAI-1 as a Target in Kidney Disease. Yufeng Huang; Noble, Nancy A. // Current Drug Targets;Sep2007, Vol. 8 Issue 9, p1007 

    Fibrotic renal diseases represent a major health care problem because of their prevalence and the fact that available therapies merely slow, but do not halt progression to renal failure. New therapies to further slow or stop the progression to end stage of renal disease (ESRD) are urgently...

  • Modulation of glomerulosclerosis. Ma, Li-Jun; Fogo, Agnes // Seminars in Immunopathology;2007, Vol. 29 Issue 4, p385 

    Regardless of the initial injury, the long-term consequence for the patient depends upon the ensuing balance of profibrotic vs reparative modulators activated. The glomerulus has some capacity for repair. Even when sclerosis has developed with accumulation of extracellular matrix, this lesion...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics